Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Toth Financial Advisory Corp

Toth Financial Advisory Corp trimmed its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 19.5% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 120 shares of the medical equipment provider’s stock after selling 29 shares during the period. Toth Financial Advisory Corp’s holdings in Intuitive Surgical were worth $48,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. Baystate Wealth Management LLC grew its holdings in Intuitive Surgical by 150.0% during the 4th quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 45 shares in the last quarter. MCF Advisors LLC grew its holdings in Intuitive Surgical by 108.1% during the 4th quarter. MCF Advisors LLC now owns 77 shares of the medical equipment provider’s stock worth $26,000 after acquiring an additional 40 shares in the last quarter. Able Wealth Management LLC acquired a new position in Intuitive Surgical during the 4th quarter worth $28,000. Atticus Wealth Management LLC grew its holdings in Intuitive Surgical by 85.4% during the 4th quarter. Atticus Wealth Management LLC now owns 89 shares of the medical equipment provider’s stock worth $30,000 after acquiring an additional 41 shares in the last quarter. Finally, MeadowBrook Investment Advisors LLC bought a new position in shares of Intuitive Surgical in the 4th quarter worth about $30,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Intuitive Surgical

In other news, Director Craig H. Barratt sold 1,400 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, June 12th. The shares were sold at an average price of $421.06, for a total value of $589,484.00. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. In related news, SVP Mark Brosius sold 175 shares of the business’s stock in a transaction that occurred on Monday, May 13th. The shares were sold at an average price of $389.16, for a total transaction of $68,103.00. Following the transaction, the senior vice president now directly owns 883 shares of the company’s stock, valued at $343,628.28. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Craig H. Barratt sold 1,400 shares of the business’s stock in a transaction that occurred on Wednesday, June 12th. The shares were sold at an average price of $421.06, for a total transaction of $589,484.00. The disclosure for this sale can be found here. Insiders have sold a total of 17,956 shares of company stock valued at $6,927,011 over the last ninety days. Corporate insiders own 0.90% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on ISRG shares. Citigroup raised their price target on shares of Intuitive Surgical from $428.00 to $462.00 and gave the stock a “buy” rating in a research report on Wednesday, April 3rd. The Goldman Sachs Group assumed coverage on shares of Intuitive Surgical in a research report on Thursday, May 30th. They issued a “buy” rating and a $500.00 price target on the stock. Stifel Nicolaus lifted their price objective on shares of Intuitive Surgical from $420.00 to $430.00 and gave the company a “buy” rating in a research report on Monday, April 8th. Jefferies Financial Group lifted their price objective on shares of Intuitive Surgical from $365.00 to $375.00 and gave the company a “hold” rating in a research report on Friday, April 19th. Finally, BTIG Research lifted their price objective on shares of Intuitive Surgical from $412.00 to $421.00 and gave the company a “buy” rating in a research report on Friday, April 19th. Five equities research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $403.67.

Intuitive Surgical Price Performance

Shares of ISRG traded down $0.26 during mid-day trading on Friday, hitting $444.85. The company’s stock had a trading volume of 3,106,192 shares, compared to its average volume of 1,372,778. The firm has a 50-day moving average price of $403.83 and a 200 day moving average price of $382.69. The stock has a market capitalization of $157.79 billion, a price-to-earnings ratio of 80.30, a PEG ratio of 5.75 and a beta of 1.39. Intuitive Surgical, Inc. has a fifty-two week low of $254.85 and a fifty-two week high of $447.11.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.40 by $0.10. The company had revenue of $1.89 billion for the quarter, compared to analysts’ expectations of $1.87 billion. Intuitive Surgical had a net margin of 27.16% and a return on equity of 12.91%. The business’s revenue was up 11.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.00 EPS. As a group, equities analysts anticipate that Intuitive Surgical, Inc. will post 4.8 EPS for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.